Results 21 to 30 of about 377,194 (138)

Durability of the neutralizing antibody response to vaccine and non-vaccine HPV types 7 years following immunization with either Cervarix® or Gardasil® vaccine [PDF]

open access: yes, 2019
Bivalent (Cervarix®) and quadrivalent (Gardasil®) Human Papillomavirus (HPV) vaccines demonstrate remarkable efficacy against the targeted genotypes, HPV16 and HPV18, but also a degree of cross-protection against non-vaccine incorporated genotypes, HPV31
Andrews, N   +8 more
core   +1 more source

High human papillomavirus prevalence among females attending high school in the Eastern Cape Province of South Africa.

open access: yesPLoS ONE, 2021
As part of the human papillomavirus (HPV) vaccination strategy in South Africa, it is essential to have information on HPV prevalence, and HPV types distribution among the unvaccinated population. Information on the prevalence of HPV and the distribution
Zizipho Z A Mbulawa   +3 more
doaj   +1 more source

Binding antibody levels to vaccine (HPV6/11/16/18) and non-vaccine (HPV31/33/45/52/58) HPV antigens up to 7 years following immunization with either Cervarix® or Gardasil® vaccine [PDF]

open access: yes, 2022
Human Papillomavirus (HPV) bivalent (Cervarix®) and quadrivalent (Gardasil®) vaccines demonstrate robust efficacy against vaccine types and cross-protection against related non-vaccine types.
Turner, Paul   +7 more
core   +2 more sources

Relationship between HPV-specific vaccine antibodies in sera and genital samples. [PDF]

open access: yes, 2013
(A) Neutralization titers were normalized to IgG levels in serum and genital samples for HPV16 (left panel; Cervarix® n = 21, Gardasil® n = 28) and HPV18 (right panel; Cervarix® n = 21, Gardasil® n = 26).
Rebecca Howell-Jones (408906)   +8 more
core   +1 more source

Cross-neutralizing antibody titres against non-vaccine types induced by a recombinant trivalent HPV vaccine (16/18/58) in rhesus macaques

open access: yesPapillomavirus Research, 2020
Human papillomavirus (HPV) causes not only most cervical cancers but also cancers of the vagina, vulva, penis, anus, rectum, and oropharynx. Every year, 200,000 women die of cervical cancer in the world, and China accounts for about 10%. HPV vaccines are
Yan Wang   +5 more
doaj   +1 more source

Diagnostic value of Xpert® BC Detection, Bladder Epicheck®, Urovysion® FISH and cytology in the detection of upper urinary tract urothelial carcinoma. [PDF]

open access: yes, 2023
PURPOSE Following the current guidelines, diagnosis and staging for upper urinary tract tumours (UTUC) can be performed with Computed Tomography, urography, ureterorenoscopy (URS) and selective cytology.
Danuser, Hansjörg   +17 more
core   +1 more source

Collecting, archiving and processing DNA from wildlife samples using FTA® databasing paper [PDF]

open access: yes, 2004
Background Methods involving the analysis of nucleic acids have become widespread in the fields of traditional biology and ecology, however the storage and transport of samples collected in the field to the laboratory in such a manner to allow ...
LA Burgoyne   +3 more
core   +1 more source

EFFICACY OF VACCINE PREVENTION OF HPV-ASSOCIATED DISEASES AND CERVICAL CANCER IN THE MOSCOW REGION

open access: yesAlʹmanah Kliničeskoj Mediciny, 2016
Data on high prevalence of papilloma virus infection and associated disorders in adults as well as in adolescents are becoming more and more frequently published in the world and domestic literature.
V. I. Krasnopol'skiy   +5 more
doaj   +1 more source

Ongoing challenges and future directions of human papillomavirus vaccination

open access: yesБезопасность и риск фармакотерапии, 2020
Cervical cancer caused by human papillomavirus (HPV) types 16 and 18 is one of the most common cancer types in women. Other high-risk HPV types may cause vaginal cancer, vulval cancer, penile cancer, anal cancer, head and neck cancer. Low-risk HPV types,
O. S. Alyautdina, V. Yu. Prilutskaya
doaj   +1 more source

Knowledge, attitude, practice and barriers on vaccination against human papillomavirus infection: a cross-sectional study among primary care physicians in Hong Kong. [PDF]

open access: yesPLoS ONE, 2013
This study explored the knowledge, attitude, practice and barriers to prescribe human papillomavirus (HPV) vaccines among private primary care physicians in Hong Kong.
Martin C S Wong   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy